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ABSTRACT
Context: The focus of this review is to compile the different chromatographic methods that were reported earlier for the analysis of different 
antihypertensive and antidiabetic drugs.
Objective: The magnitude of chemical entities investigated and entering into the medicinal field for various health-related ailments is escalating year 
after year. The drugs are either innovative entities or fractional structural variation of the preexisting chemical molecule. These drugs may exhibit 
unexpected toxicities after Phase IV of clinical trials, resulting in their withdrawal from the market. Under these circumstances, analytical measures 
for these drugs may not be accessible in the pharmacopeias. The main aim of this work is to compile the different analytical techniques for the 
quantification of various antihypertensive drugs and antidiabetic drugs.
Methods: The present work is to thoroughly study the literature for the application of different analytical techniques such as high-performance 
liquid chromatography (HPLC) and liquid chromatography-mass spectroscopy/tandem mass spectroscopy (LC-MS/MS) for the quantification of 
antihypertensive drugs and anti-diabetic drugs.
Results: The present study attempts to collate various analytical techniques that were developed and validated for the estimation of few important 
antidiabetic and antihypertensive drugs either in pure, individually or combined with other pharmaceutical dosage form by HPLC, LC-MS/MS, and 
high-performance thin-layer chromatography techniques.
Conclusion: Different chromatographic methods are considered to be rapid tools for qualitative and quantitative analysis of newer chemical entities 
in pharmaceuticals. The amount of these newer chemical entities which are reaching the pharmaceutical market is increasing day by day nevertheless 
there exists a lag in establishing the standard protocols for the identification, impurity profiling, related substance and assay method. Hence, the 
present review compiles the different analytical methods that were reported in the literature and thus helps the researchers and chemists to make 
use of the analytical techniques for the quantification and validation of various antidiabetic and antihypertensive drugs.
Keywords: Liquid chromatography, High-performance liquid chromatography, Antihypertensive, Antidiabetic, Oral hypoglycemics, Liquid 
chromatography-mass spectroscopy/tandem mass spectroscopy.
INTRODUCTION
Nowadays, hypertension is prevalently seen among individuals across 
the world and is an important modifiable risk factor for various 
cardiovascular ailments. It ultimately affects the functioning of the 
heart, kidney, and brain. Antihypertensive drugs comprise vasodilators, 
diuretics, angiotensin receptor blockers, and sympathoplegic 
agents [1]. Vasodilators reduce the tension in the vascular muscle; a 
diuretic depletes the levels of sodium and lessens the volume of blood; 
angiotensin receptor blockers hinder the angiotensin-converting 
enzyme; and sympathoplegic agents taper off the cardiac output [2].
Elevated levels of glucose in blood and fluctuations in the levels of 
insulin production by the pancreas provoke the disease called diabetes 
mellitus. Other than insulins, oral hypoglycemics such as antidiabetic 
drugs comprise thiazolidinediones, biguanides, incretin-based drugs, 
sulfonylureas, alpha-glucosidase inhibitors, glitinides and amylin 
analog. All these drugs help to regulate the amount of insulin in the 
blood [3].
The important objective of this study is to collate the different 
bioanalytical techniques that are available for various drugs in the 
class of antihypertensives and antidiabetics. Accordingly, a thorough 
literature search from the PUBMED (NCBI) database using appropriate 
keywords was performed. Table 1 summarizes the salient features of 
different antihypertensive and antidiabetic drugs. The present review 
compiles the reported bioanalytical methods with more emphasis for 
approved drugs such as pioglitazone, metformin, glipizide, amlodipine, 
nifedipine, valsartan, and captopril.
Hence, the present manuscript is based on the various analytical 
method developments and validation carried out for antihypertensive 
and antidiabetic drugs. In this review, a detailed study on the assay, 
impurity profiling, and stability indication assay, bio-analytical 
methods that were carried out by various chromatographic methods 
are discussed for hypertension and diabetes drugs in their pure form, 
individually or in combined pharmaceutical dosage form.
Analysis involving liquid chromatography-mass spectroscopy/
tandem mass spectroscopy (LC-MS/MS)
Pioglitazone and its metabolic products (III and IV) were analyzed 
in the plasma using LC–MS/MS involving electrospray tandem mass 
spectrometer system. The drug was extracted from plasma using liquid-
liquid extraction (LLE) with methyl t-butyl ether:n-butyl chloride 
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1:1 (v/v). The calibration range was found to be 0.5–2000 ng/mL [4]. 
Pioglitazone and candesartan were extracted from 0.1 mL human 
plasma by SP extraction with reversed phase column (C18 column), 
and organic phase consists of 20:80 (v/v) formic acid (0.1%) and 
acetonitrile [5]. Tolbutamide and its related substances were studied 
in rat plasma by sim in positive mode using C18 (Zorbax) column using 
0.1% formic acid along with acetonitrile used as eluant. Extraction 
was achieved by liquid-liquid scheme using ethyl acetate [6]. The 
separation of drugs such as sitagliptin and metformin in human plasma 
was studied using SCX column involving biochemical partition using 
acetonitrile (ACN) (50):50% of ammonium acetate buffer (20 mM) as 
mobile phase, and pH was maintained at acidic condition during the 
course of analysis [7].
LC-MS study was carried out using human plasma for the determination 
of metformin, atorvastatin, and glimepiride [8]. The extraction was 
done with protein precipitation with acetonitrile. Pharmacokinetic 
parameters were investigated in nifedipine, montelukast, and 
gliclazide, and they were analyzed using SB-C18 with formic acid (0.1%) 
84:16 acetonitrile as mobile phase [9]. Analysis of sacubitril and 
valsartan in rat plasma was carried out using liquid chromatography, 
and further, the eluent was subjected for ionization by ESI in positive 
mode. The study was carried out using Hypersil GOLD C18 column, with 
acetonitrile and formic acid (0.1%) as mobile phase. Before the analysis, 
the drugs were extracted using deproteinization [10]. Extraction of 
metformin, ramipril, and glimepiride from the plasma was performed 
by LLE using 50% butanol and 50% n-hexane, and further, separation 
was achieved by organic phase containing 90% of methanol and 10% 
of formic acid (0.1%) in aqueous medium by ultra-performance liquid 
chromatography (UPLC) partition using C18 column. The eluent was 
further studied with multireaction monitoring tandem quadrupole 
mass spectrometer [11]. Hypersil GOLD C18 (50 mm 3.0 mm, 5 µm) 
column using 15% of ammonium formate (5.0 mM) and 85% of 
acetonitrile as eluent in acidic conditions (pH 4.5) was employed for 
the resolution of hydrochlorothiazide and lisinopril [12].
Antihypertensive (β-blockers) and broncho agonist in plasma and urine 
were extracted using determined using solid phase microextraction 
method, and later, they were analyzed using pentafluorophenyl stationary 
phase and the mobile phase comprised of acetonitrile and water [13]. 
Telmisartan and pioglitazone were estimated using C18 (50 mm 4.6 mm 
5 µm) column with methanol-ammonium formate (10 mM) mixture 
(9:1, v/v) as eluent [14]. Healthy Chinese subjects were used for the 
estimation of amlodipine in human plasma [15]. Glimepiride and 
atorvastatin are estimated in human plasma by LCMS/MS. Extraction 
was performed by liquid-liquid method. The US FDA guidelines were 
followed for the method development and validation [16].
Analysis using high-performance liquid chromatography (HPLC)
Telmisartan and pioglitazone were simultaneously separated using 
ODS-3v column with 65% of ammonium dihydrogen phosphate buffer 
(pH 4.5) and 35% of acetonitrile as mobile phase and the retention times 
were found to be 2.38 min (telmisartan) and 3.16 min (pioglitazone), 
respectively [17]. Glimepiride, vildagliptin, and pioglitazone 
hydrochloride were estimated using HPLC coupled to UV detector, 
where the separation was achieved using Hypersil GOLD C18 reverse 
phase column with 45% of acetonitrile and 55% of 0.05 M potassium 
dihydrogen phosphate buffer as eluent, and the retention times 
were found to be vildagliptin (1.27 min), pioglitazone hydrochloride 
(2.71 min), and glimepiride (8.87 min) respectively [18]. In another 
study, the separation of pioglitazone hydrochloride and glimepiride 
analytes was done by HPLC using reversed phase C18 (ODS) column 
with mobile phase potassium dihydrogen phosphate buffer (pH 3.4) 
and acetonitrile (40:60 v/v) and the retention times were found to 
be 4.5±0.1 min (pioglitazone) and 10.0±0.1 min (glimepiride) [19]. In 
binary combination of carvedilol, glimepiride, or glibenclamide, the 
separation was achieved chromatographically using XDB-C18 reversed 
phased column using 30% of 0.2 M phosphate buffer (pH 3.5) and 70% 
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Chromatographic separation and validation of the combined tablet 
containing atorvastatin, metformin, and glimepiride reported using 
BEH C18 column, and eluent consists of 600 mL of acetonitrile (60%) 
and phosphate buffer (pH 3) 400 mL (40%) [21]. UPLC with PDA 
detector was used for the development of method and validation for 
metformin and telmisartan in pure solid dosage form using column 
C18 (150 × 4.6 ID) 5 µm, with sodium dihydrogen phosphate buffer 
(NaH2PO4):acetonitrile (60:40v/v) as mobile phase [22]. In another 
study, metformin hydrochloride, ramipril, and glimepiride were 
separated using mobile phase of 0.02 M KH2PO4 buffer and methanol 
(150:850) using Hypersil BDS C18 column [23].
The estimation of nifedipine, nateglinide, and lovastatin was achieved 
simultaneously by Millennium C18 column and 40% of 10 mM phosphate 
buffer (pH 3.5) and 60% acetonitrile as eluent [24]. Estimation of 
antihypertensive and antidiabetic drugs using RP-HPLC separation 
was achieved by organic and aqueous phase (60:40, v/v) [25]. 
Degradation studies of valsartan were performed using isocratic 
HPLC method with C18 reverse stationary phase, with 70% methanol 
and 30% water (pH 7.2) as mobile phase was used in acid hydrolysis 
stability-indicating assay [26]. Analysis of glibenclamide, metformin, 
captopril, and pioglitazone in API was reported with 70% methanol 
and 30% water using Hypersil ODS C18 column [27]. Glibenclamide, 
amlodipine, atorvastatin, and metformin in human plasma were 
separated and validated by HPLC-UV method [28]. Antidiabetic and 
antihypertensive drugs were studied for stability indicating assay 
using RP HPLC method; the separation was achieved isocratically on a 
C18 column [29]. In a similar study, the combination of metformin and 
telmisartan was analyzed and validated by RP-HPLC method in bulk 
and in formulations [30].
The estimation of metformin hydrochloride, glimepiride, and 
atorvastatin calcium was carried out simultaneously in bulk and 
combined dosage form by stability indicating RP-HPLC technique [31]. 
Telmisartan and metformin hydrochloride were estimated by RP-HPLC 
method in bulk and synthetic mixture [32]. The interaction of 
nifedipine and metformin in hypertension with type II diabetic patients 
was studied using ODS Hypersil column C18, using acetonitrile, 25 mM 
KH2PO4, and methanol as eluents [33].
Pioglitazone and telmisartan in a formulation were estimated by 
RP-HPLC technique using 35% of 0.5% triethylamine and 65% of 
acetonitrile [34]. High-performance thin-layer chromatography 
(HPTLC) technique was used for the estimation of metformin, 
glimepiride, and atorvastatin in fixed dosage combination using 
water:methanol:ammonium sulfate as mobile phase [35]. In a similar 
study, the determination of antidiabetic and antihypertensive drugs in 
pharmaceutical formulations was analyzed by RP-LC with Lichrocart 
C18 as a stationary phase and methanol:water:orthophosphoric 
acid (75:25:0.2) as mobile phase [36]. Simultaneous estimation of 
atorvastatin, metformin, and glimepride in the formulation was 
carried out by RP HPLC technique, and the separation was achieved by 
Hibar C18 as stationary phase using 40% of ACN and 60% ammonium 
acetate (10 mM, pH 3.0, adjusted using acetic acid) as eluent, 
respectively [37].
CONCLUSION
Chromatographic methods are considered to be rapid tools for 
qualitative and quantitative analysis of newer chemical entities 
in pharmaceuticals. In recent times, there were several new drug 
molecules that were introduced in to the market, but always there 
exists a lag in establishing a defined protocol for the analysis of 
impurities, their identification and the development of assay methods. 
Hence, this review attempts to collate various analytical techniques 
that were developed and validated for the estimation of few important 
antidiabetic and antihypertensive drugs either in pure, individually or 
combined with other pharmaceutical dosage form by HPLC, LC-MS/MS, 
and HPTLC techniques.
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